Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3029871000168116 | Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3050431000168114 | Lignocaine (Pfizer) (lidocaine hydrochloride monohydrate 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Is a | Lignocaine (Pfizer) | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 1441096762 | |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | has Australian BoSS | lidocaine hydrochloride monohydrate | true | Inferred relationship | Some | 1441096761 | |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Is a | trade product unit of use | false | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Is a | Lignocaine (Pfizer) | false | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Is a | lidocaine hydrochloride monohydrate 2% (100 mg/5 mL) injection, ampoule | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 1441096761 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules | has TPUU | True | Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 50 x 5 mL ampoules | has TPUU | True | Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules | has TPUU | True | Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Inferred relationship | Some | 1 |
| Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 50 x 5 mL ampoules | has TPUU | True | Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR